Howard Liang Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Howard Liang.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Howard Liang. Howard Liang is CFO & Chief Strategy Officer in BeiGene, Ltd. ($BGNE) and CFO & CSO in BeiGene, Ltd. ($BGNE).
Latest Insider Trading Transactions of Howard Liang
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 19 2021 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Option Exercise | M | 0.50 | 163,800 | 81,900 | 649,000 | |
| Jan 19 2021 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Option Exercise | M | 0.50 | 18,200 | 9,100 | 812,800 | |
| Jan 19 2021 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 345.54 | 5,606 | 1,937,087 | 0 | 5.6 K to 0 (-100.00 %) |
| Jan 19 2021 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 344.38 | 6,994 | 2,408,602 | 5,606 | 12.6 K to 5.6 K (-55.51 %) |
| Jan 19 2021 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Buy | M | 6.50 | 12,600 | 81,900 | 12,600 | 0 to 12.6 K |
| Jan 19 2021 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 345.15 | 300 | 103,546 | 0 | 300 to 0 (-100.00 %) |
| Jan 19 2021 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 344.28 | 1,100 | 378,710 | 300 | 1.4 K to 300 (-78.57 %) |
| Jan 19 2021 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Buy | M | 6.50 | 1,400 | 9,100 | 1,400 | 0 to 1.4 K |
| Dec 16 2020 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Option Exercise | M | 0.50 | 2,600,000 | 1,300,000 | 831,000 | |
| Dec 16 2020 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 232.19 | 700 | 162,532 | 0 | 700 to 0 (-100.00 %) |
| Dec 16 2020 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 231.11 | 17,456 | 4,034,303 | 700 | 18.2 K to 700 (-96.14 %) |
| Dec 16 2020 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 230.51 | 24,842 | 5,726,245 | 18,156 | 43 K to 18.2 K (-57.77 %) |
| Dec 16 2020 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 229.18 | 9,752 | 2,234,962 | 42,998 | 52.8 K to 43 K (-18.49 %) |
| Dec 16 2020 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 228.23 | 5,885 | 1,343,126 | 52,750 | 58.6 K to 52.8 K (-10.04 %) |
| Dec 16 2020 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 228.10 | 400 | 91,240 | 58,635 | 59 K to 58.6 K (-0.68 %) |
| Dec 16 2020 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 227.72 | 7,500 | 1,707,920 | 59,035 | 66.5 K to 59 K (-11.27 %) |
| Dec 16 2020 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 227.08 | 15,062 | 3,420,268 | 66,535 | 81.6 K to 66.5 K (-18.46 %) |
| Dec 16 2020 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 226.40 | 6,203 | 1,404,377 | 81,597 | 87.8 K to 81.6 K (-7.06 %) |
| Dec 16 2020 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 225.24 | 4,100 | 923,480 | 87,800 | 91.9 K to 87.8 K (-4.46 %) |
| Dec 16 2020 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Buy | M | 6.50 | 91,900 | 597,350 | 91,900 | 0 to 91.9 K |
| Dec 16 2020 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Buy | M | 0.50 | 1,405,300 | 702,650 | 1,573,715 | 168.4 K to 1.6 M (+834.43 %) |
| Oct 07 2020 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Option Exercise | M | 0.50 | 182,000 | 91,000 | 3,431,000 | |
| Oct 07 2020 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Option Exercise | M | 0.50 | 182,000 | 91,000 | 3,431,000 | |
| Oct 07 2020 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 304.15 | 300 | 91,245 | 0 | 300 to 0 (-100.00 %) |
| Oct 07 2020 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 304.15 | 300 | 91,245 | 0 | 300 to 0 (-100.00 %) |
| Oct 07 2020 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 303.24 | 1,869 | 566,757 | 300 | 2.2 K to 300 (-86.17 %) |
| Oct 07 2020 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 303.24 | 1,869 | 566,757 | 300 | 2.2 K to 300 (-86.17 %) |
| Oct 07 2020 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 302.11 | 2,831 | 855,260 | 2,169 | 5 K to 2.2 K (-56.62 %) |
| Oct 07 2020 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 302.11 | 2,831 | 855,260 | 2,169 | 5 K to 2.2 K (-56.62 %) |
| Oct 07 2020 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 300.88 | 1,499 | 451,024 | 5,000 | 6.5 K to 5 K (-23.07 %) |
| Oct 07 2020 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 300.88 | 1,499 | 451,024 | 5,000 | 6.5 K to 5 K (-23.07 %) |
| Oct 07 2020 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 300.09 | 2,001 | 600,469 | 6,499 | 8.5 K to 6.5 K (-23.54 %) |
| Oct 07 2020 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 300.09 | 2,001 | 600,469 | 6,499 | 8.5 K to 6.5 K (-23.54 %) |
| Oct 07 2020 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 298.97 | 1,000 | 298,966 | 8,500 | 9.5 K to 8.5 K (-10.53 %) |
| Oct 07 2020 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 298.97 | 1,000 | 298,966 | 8,500 | 9.5 K to 8.5 K (-10.53 %) |
| Oct 07 2020 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 297.98 | 1,200 | 357,573 | 9,500 | 10.7 K to 9.5 K (-11.21 %) |
| Oct 07 2020 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 297.98 | 1,200 | 357,573 | 9,500 | 10.7 K to 9.5 K (-11.21 %) |
| Oct 07 2020 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 296.47 | 500 | 148,237 | 10,700 | 11.2 K to 10.7 K (-4.46 %) |
| Oct 07 2020 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 296.47 | 500 | 148,237 | 10,700 | 11.2 K to 10.7 K (-4.46 %) |
| Oct 07 2020 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 295.73 | 568 | 167,973 | 11,200 | 11.8 K to 11.2 K (-4.83 %) |
| Oct 07 2020 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 295.73 | 568 | 167,973 | 11,200 | 11.8 K to 11.2 K (-4.83 %) |
| Oct 07 2020 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 294.92 | 1,415 | 417,313 | 11,768 | 13.2 K to 11.8 K (-10.73 %) |
| Oct 07 2020 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 294.92 | 1,415 | 417,313 | 11,768 | 13.2 K to 11.8 K (-10.73 %) |
| Oct 07 2020 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 293.26 | 817 | 239,596 | 13,183 | 14 K to 13.2 K (-5.84 %) |
| Oct 07 2020 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 293.26 | 817 | 239,596 | 13,183 | 14 K to 13.2 K (-5.84 %) |
| Oct 07 2020 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Buy | M | 6.50 | 14,000 | 91,000 | 14,000 | 0 to 14 K |
| Oct 07 2020 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Buy | M | 6.50 | 14,000 | 91,000 | 14,000 | 0 to 14 K |
| Sep 16 2020 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Option Exercise | M | 0.50 | 182,000 | 91,000 | 3,613,000 | |
| Sep 16 2020 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 252.59 | 103 | 26,017 | 0 | 103 to 0 (-100.00 %) |
| Sep 16 2020 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 251.95 | 2,181 | 549,512 | 103 | 2.3 K to 103 (-95.49 %) |
| Sep 16 2020 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 250.71 | 3,157 | 791,480 | 2,284 | 5.4 K to 2.3 K (-58.02 %) |
| Sep 16 2020 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 249.97 | 6,478 | 1,619,317 | 5,441 | 11.9 K to 5.4 K (-54.35 %) |
| Sep 16 2020 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 248.93 | 1,681 | 418,454 | 11,919 | 13.6 K to 11.9 K (-12.36 %) |
| Sep 16 2020 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 247.46 | 400 | 98,985 | 13,600 | 14 K to 13.6 K (-2.86 %) |
| Sep 16 2020 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Buy | M | 6.50 | 14,000 | 91,000 | 14,000 | 0 to 14 K |
| Jul 01 2020 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 191.23 | 300 | 57,368 | 0 | 300 to 0 (-100.00 %) |
| Jun 19 2020 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Option Exercise | A | 13.42 | 315,341 | 4,231,876 | 315,341 | |
| Jun 19 2020 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Grant | A | 0.00 | 55,887 | 0 | 172,315 | 116.4 K to 172.3 K (+48.00 %) |
| Jun 10 2020 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 170.84 | 453 | 77,391 | 0 | 453 to 0 (-100.00 %) |
| Nov 20 2019 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Option Exercise | M | 0.50 | 325,000 | 162,500 | 3,795,000 | |
| Nov 20 2019 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 198.93 | 400 | 79,572 | 0 | 400 to 0 (-100.00 %) |
| Nov 20 2019 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 197.55 | 200 | 39,510 | 400 | 600 to 400 (-33.33 %) |
| Nov 20 2019 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 196.63 | 200 | 39,326 | 600 | 800 to 600 (-25.00 %) |
| Nov 20 2019 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 195.57 | 5,633 | 1,101,671 | 800 | 6.4 K to 800 (-87.56 %) |
| Nov 20 2019 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 194.62 | 8,156 | 1,587,311 | 6,433 | 14.6 K to 6.4 K (-55.91 %) |
| Nov 20 2019 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 193.60 | 6,944 | 1,344,334 | 14,589 | 21.5 K to 14.6 K (-32.25 %) |
| Nov 20 2019 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 192.63 | 2,311 | 445,168 | 21,533 | 23.8 K to 21.5 K (-9.69 %) |
| Nov 20 2019 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 191.80 | 1,156 | 221,724 | 23,844 | 25 K to 23.8 K (-4.62 %) |
| Nov 20 2019 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Buy | M | 6.50 | 25,000 | 162,500 | 25,000 | 0 to 25 K |
| Jul 01 2019 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 9.47 | 5,876 | 55,653 | 122,317 | 128.2 K to 122.3 K (-4.58 %) |
| Jun 07 2019 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Option Exercise | A | 9.23 | 558,285 | 5,152,971 | 558,285 | |
| Jun 07 2019 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Grant | A | 0.00 | 75,855 | 0 | 128,193 | 52.3 K to 128.2 K (+144.93 %) |
| May 22 2019 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Option Exercise | M | 0.50 | 301,600 | 150,800 | 4,120,000 | |
| May 22 2019 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 130.21 | 23,200 | 3,020,860 | 0 | 23.2 K to 0 (-100.00 %) |
| May 22 2019 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Buy | M | 6.50 | 23,200 | 150,800 | 23,200 | 0 to 23.2 K |
| May 08 2019 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Option Exercise | M | 0.50 | 23,400 | 11,700 | 4,421,600 | |
| May 08 2019 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 130.01 | 1,800 | 234,014 | 0 | 1.8 K to 0 (-100.00 %) |
| May 08 2019 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Buy | M | 6.50 | 1,800 | 11,700 | 1,800 | 0 to 1.8 K |
| Jun 28 2018 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Option Exercise | A | 12.34 | 364,208 | 4,494,327 | 364,208 | |
| Jun 28 2018 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Grant | A | 0.00 | 52,338 | 0 | 52,338 | 0 to 52.3 K |
| Mar 20 2018 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Option Exercise | M | 0.50 | 313,664 | 156,832 | 4,445,000 | |
| Mar 20 2018 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Option Exercise | M | 0.50 | 141,336 | 70,668 | 4,758,664 | |
| Mar 20 2018 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 164.36 | 900 | 147,923 | 0 | 900 to 0 (-100.00 %) |
| Mar 20 2018 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 163.48 | 4,636 | 757,902 | 900 | 5.5 K to 900 (-83.74 %) |
| Mar 20 2018 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 162.79 | 5,133 | 835,583 | 5,536 | 10.7 K to 5.5 K (-48.11 %) |
| Mar 20 2018 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 161.62 | 3,141 | 507,661 | 10,669 | 13.8 K to 10.7 K (-22.74 %) |
| Mar 20 2018 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 160.60 | 9,618 | 1,544,652 | 13,810 | 23.4 K to 13.8 K (-41.05 %) |
| Mar 20 2018 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 159.62 | 5,200 | 830,042 | 23,428 | 28.6 K to 23.4 K (-18.16 %) |
| Mar 20 2018 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 158.45 | 500 | 79,224 | 28,628 | 29.1 K to 28.6 K (-1.72 %) |
| Mar 20 2018 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Buy | M | 6.50 | 24,128 | 156,832 | 29,128 | 5 K to 29.1 K (+482.56 %) |
| Mar 20 2018 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 157.98 | 400 | 63,191 | 5,000 | 5.4 K to 5 K (-7.41 %) |
| Mar 20 2018 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 157.41 | 7,264 | 1,143,430 | 5,400 | 12.7 K to 5.4 K (-57.36 %) |
| Mar 20 2018 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 156.75 | 2,208 | 346,095 | 12,664 | 14.9 K to 12.7 K (-14.85 %) |
| Mar 20 2018 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 154.95 | 1,000 | 154,950 | 14,872 | 15.9 K to 14.9 K (-6.30 %) |
| Mar 20 2018 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Buy | M | 6.50 | 10,872 | 70,668 | 15,872 | 5 K to 15.9 K (+217.44 %) |
| Jun 29 2017 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & CSO | Option Exercise | A | 3.46 | 1,250,000 | 4,325,000 | 1,250,000 | |
| Nov 18 2016 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & CSO | Option Exercise | A | 2.84 | 1,752,500 | 4,977,100 | 1,752,500 | |
| Feb 09 2016 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Buy | P | 1.85 | 65,000 | 120,250 | 65,000 | 0 to 65 K |
Page: 1